Marshall Fordyce, PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 28,942 shares at $39.76 ($1.2M) on 2024-08-21, disclosed to the SEC on 2024-08-23.
Open-market sale of $1.2M VERA by PRESIDENT AND CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.76 | 14,471 | $575K | 50.0% |
| 2 | $39.76 | 14,471 | $575K | 50.0% |
| Total | $39.76 avg | 28,942 | $1.2M | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |